Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


19.03.2018

2 Am J Cardiol
2 Ann Thorac Surg
4 Atherosclerosis
2 Circ Cardiovasc Imaging
1 Circ Cardiovasc Interv
2 Circ Cardiovasc Qual Outcomes
1 Circ Heart Fail
1 Circ Res
7 Circulation
1 Clin Cardiol
2 Eur Heart J
1 Heart
10 Int J Cardiol
6 J Am Coll Cardiol
2 J Mol Cell Cardiol
4 J Thorac Cardiovasc Surg
2 JAMA
3 Lancet
1 N Engl J Med
4 PLoS One
1 Psychosom Med
2 Thromb Haemost


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. TIBUAKUU M, Kianoush S, DeFilippis AP, McEvoy JW, et al
    Usefulness of Lipoprotein-Associated Phospholipase A2 Activity and C-Reactive Protein in Identifying High-Risk Smokers for Atherosclerotic Cardiovascular Disease (from the Atherosclerosis Risk in Communities Study).
    Am J Cardiol. 2018 Feb 6. pii: S0002-9149(18)30162.
    PubMed     Text format     Abstract available

  2. FRANCK C, Filion KB, Eisenberg MJ
    Smoking Cessation in Patients With Acute Coronary Syndrome.
    Am J Cardiol. 2018 Feb 6. pii: S0002-9149(18)30159.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  3. BELLER JP, Hawkins RB, Mehaffey JH, LaPar DJ, et al
    Does Preoperative Troponin Level Impact Outcomes following Coronary Artery Bypass Grafting?
    Ann Thorac Surg. 2018 Mar 8. pii: S0003-4975(18)30276.
    PubMed     Text format     Abstract available

  4. FRIGAULT J, Lafreniere-Bessi V, Perron J, Bedard E, et al
    Anomalous Left Coronary Artery from the Pulmonary Artery: Masquerading as Peripartum Cardiomyopathy.
    Ann Thorac Surg. 2018 Mar 9. pii: S0003-4975(18)30324.
    PubMed     Text format     Abstract available


    Atherosclerosis

  5. WANG A, Kwee LC, Grass E, Neely ML, et al
    Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.
    Atherosclerosis. 2017;261:19-25.
    PubMed     Text format     Abstract available

  6. NAKAJIMA S, Ito H, Mitsuhashi T, Kubo Y, et al
    Clinical application of effective atomic number for classifying non-calcified coronary plaques by dual-energy computed tomography.
    Atherosclerosis. 2017;261:138-143.
    PubMed     Text format     Abstract available

  7. TADA H, Kawashiri MA, Sakata K, Yoneda T, et al
    Renal glucosuria is not associated with atherosclerotic cardiovascular disease outcome in a general Japanese community.
    Atherosclerosis. 2017;261:111-116.
    PubMed     Text format     Abstract available

  8. FAIROOZY RH, Cooper J, White J, Giambartolomei C, et al
    Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene.
    Atherosclerosis. 2017;261:60-68.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Imaging

  9. LONG MT, Benjamin EJ
    Prevalent Cardiovascular Disease Events and T1 Mapping Defined Hepatic Fibrosis.
    Circ Cardiovasc Imaging. 2018;11:e007553.
    PubMed     Text format    

  10. OSTOVANEH MR, Ambale-Venkatesh B, Fuji T, Bakhshi H, et al
    Association of Liver Fibrosis With Cardiovascular Diseases in the General Population: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Circ Cardiovasc Imaging. 2018;11:e007241.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Interv

  11. RAPHAEL CE, Singh M, Bell M, Crusan D, et al
    Sex Differences in Long-Term Cause-Specific Mortality After Percutaneous Coronary Intervention: Temporal Trends and Mechanisms.
    Circ Cardiovasc Interv. 2018;11:e006062.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Qual Outcomes

  12. WADHERA RK, Joynt Maddox KE, Wang Y, Shen C, et al
    Association Between 30-Day Episode Payments and Acute Myocardial Infarction Outcomes Among Medicare Beneficiaries.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004397.
    PubMed     Text format     Abstract available

  13. KO DT, Krumholz HM, Tu JV, Austin PC, et al
    Clinical Outcomes of Plavix and Generic Clopidogrel for Patients Hospitalized With an Acute Coronary Syndrome.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004194.
    PubMed     Text format     Abstract available


    Circ Heart Fail

  14. HAMMOND CA, Blades NJ, Chaudhry SI, Dodson JA, et al
    Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study).
    Circ Heart Fail. 2018;11:e004476.
    PubMed     Text format     Abstract available


    Circ Res

  15. MENNI C, Gudelj I, MacDonald-Dunlop E, Mangino M, et al
    Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated with Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts.
    Circ Res. 2018 Mar 13. pii: CIRCRESAHA.117.312174.
    PubMed     Text format     Abstract available


    Circulation

  16. RADHOLM K, Figtree G, Perkovic V, Solomon SD, et al
    Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.034222.
    PubMed     Text format     Abstract available

  17. FRANCHI F, Rollini F, Rivas Rios J, Rivas A, et al
    Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP (Switching Antiplatelet Therapy)-4 Study.
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.033983.
    PubMed     Text format     Abstract available

  18. BOHULA EA, Giugliano RP, Leiter LA, Verma S, et al
    Inflammatory and Cholesterol Risk in the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk).
    Circulation. 2018 Mar 12. pii: CIRCULATIONAHA.118.034032.
    PubMed     Text format     Abstract available

  19. SCOTT JM, Nilsen TS, Gupta D, Jones LW, et al
    Exercise Therapy and Cardiovascular Toxicity in Cancer.
    Circulation. 2018;137:1176-1191.
    PubMed     Text format     Abstract available

  20. CREA F, Liuzzo G
    Addressing Acute Coronary Syndromes: New Challenges and Opportunities After the CANTOS Trial (Canakinumab Anti-inflammatory Thrombosis Outcomes Study).
    Circulation. 2018;137:1100-1102.
    PubMed     Text format    

  21. SMILOWITZ NR, Beckman JA, Sherman SE, Berger JS, et al
    Hospital Readmission After Perioperative Acute Myocardial Infarction Associated With Noncardiac Surgery.
    Circulation. 2018 Mar 10. pii: CIRCULATIONAHA.117.032086.
    PubMed     Text format     Abstract available

  22. NADRUZ W JR, Claggett B, Henglin M, Shah AM, et al
    Widening Racial Differences in Risks for Coronary Heart Disease.
    Circulation. 2018;137:1195-1197.
    PubMed     Text format    


    Clin Cardiol

  23. GILGEN N, Farah A, Scheller B, Ohlow MA, et al
    Drug-Coated Balloons for De-Novo Lesions in Small Coronary Arteries: Rationale and Design of BASKET-SMALL 2.
    Clin Cardiol. 2018 Mar 11. doi: 10.1002/clc.22942.
    PubMed     Text format     Abstract available


    Eur Heart J

  24. QAYYUM F, Lauridsen BK, Frikke-Schmidt R, Kofoed KF, et al
    Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
    Eur Heart J. 2018 Feb 23. pii: 4907930. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. THYGESEN K, Jaffe AS
    The prognostic impact of periprocedural myocardial infarction and injury.
    Eur Heart J. 2018 Feb 26. pii: 4911112. doi: 10.1093.
    PubMed     Text format    


    Heart

  26. GRIMALDI-BENSOUDA L, Danchin N, Dallongeville J, Falissard B, et al
    Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.
    Heart. 2018 Mar 13. pii: heartjnl-2017-312534. doi: 10.1136/heartjnl-2017-312534
    PubMed     Text format     Abstract available


    Int J Cardiol

  27. BORGHI C, Cicero AFG
    Serum uric acid and acute coronary syndrome: Is there a role for functional markers of residual cardiovascular risk?
    Int J Cardiol. 2018;250:62-63.
    PubMed     Text format    

  28. KRAAL JJ, Vromen T, Spee R, Kemps HMC, et al
    Comment on: "The influence of training characteristics on the effect of exercise training in patients with coronary artery disease: Systematic review and meta-regression analysis".
    Int J Cardiol. 2017;249:82.
    PubMed     Text format    

  29. KARAMI M, Khazaei S
    Comment on "The influence of training characteristics on the effect of exercise training in patients with coronary artery disease: Systematic review and meta-regression analysis".
    Int J Cardiol. 2017;249:81.
    PubMed     Text format    

  30. MAAS AHEM
    Vasospastic angina behaves differently in men and women.
    Int J Cardiol. 2017;249:79-80.
    PubMed     Text format    

  31. SAVARESE G, Lund LH
    Ticagrelor versus prasugrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An unresolved issue.
    Int J Cardiol. 2017;249:77-78.
    PubMed     Text format    

  32. SUGIYAMA T, Kimura S
    Reply to letter to the editor: "Plaque vulnerability, post-PCI tissue prolapse and neoatherosclerosis".
    Int J Cardiol. 2017;249:503.
    PubMed     Text format    

  33. WANG M, Ye J, Liu J, Wan J, et al
    High-temperature requirement protein A2 (HtrA2): A promising biomarker to predict the ischemia-reperfusion injuries in STEMI patients.
    Int J Cardiol. 2017;249:436.
    PubMed     Text format    

  34. ANDREINI D, Conte E, Mushtaq S
    Cardiac-CT in 2017: Over the coronary artery assessment.
    Int J Cardiol. 2017;249:497-499.
    PubMed     Text format    

  35. NYULAS T, Chitu M, Benedek T
    Plaque vulnerability, post-PCI tissue prolapse and neoatherosclerosis.
    Int J Cardiol. 2017;249:502.
    PubMed     Text format    

  36. CREMER PC
    The evolving purpose of imaging for low risk patients with suspected acute coronary syndromes.
    Int J Cardiol. 2017;249:494-495.
    PubMed     Text format    


    J Am Coll Cardiol

  37. PHILLIPS RA, Xu J, Peterson LE, Arnold RM, et al
    Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension.
    J Am Coll Cardiol. 2018 Mar 2. pii: S0735-1097(18)33226.
    PubMed     Text format     Abstract available

  38. DEFILIPPIS EM, Singh A, Divakaran S, Gupta A, et al
    Cocaine and Marijuana Use among Young Adults Presenting with Myocardial Infarction: The Partners YOUNG-MI Registry.
    J Am Coll Cardiol. 2018 Mar 5. pii: S0735-1097(18)33383.
    PubMed     Text format     Abstract available

  39. KOSIBOROD M, Lam CSP, Kohsaka S, Kim DJ, et al
    Lower Cardiovascular Risk Associated with SGLT-2i in >400,000 Patients: The CVD-REAL 2 Study.
    J Am Coll Cardiol. 2018 Mar 7. pii: S0735-1097(18)33528.
    PubMed     Text format     Abstract available

  40. GREENE SJ, Vaduganathan M, Khan MS, Bakris GL, et al
    Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2018 Mar 10. pii: S0735-1097(18)30326.
    PubMed     Text format     Abstract available

  41. NOTARANGELO FM, Maglietta G, Bevilacqua P, Cereda M, et al
    Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Acute Coronary Syndromes: PHARMCLO trial.
    J Am Coll Cardiol. 2018 Feb 24. pii: S0735-1097(18)33306.
    PubMed     Text format     Abstract available

  42. SAEED A, Nambi V, Sun W, Virani SS, et al
    Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults.
    J Am Coll Cardiol. 2018 Mar 3. pii: S0735-1097(18)33484.
    PubMed     Text format     Abstract available


    J Mol Cell Cardiol

  43. GUPTA K, Phan N, Wang Q, Liu B, et al
    Necroptosis in cardiovascular disease - a new therapeutic target.
    J Mol Cell Cardiol. 2018 Mar 7. pii: S0022-2828(18)30066.
    PubMed     Text format     Abstract available

  44. KAIN V, Ingle KA, Kabarowski J, Barnes S, et al
    Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.
    J Mol Cell Cardiol. 2018 Mar 8. pii: S0022-2828(18)30067.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  45. POTZ BA, Scrimgeour LA, Sabe SA, Clements RT, et al
    Glycogen synthase kinase 3beta inhibition reduces mitochondrial oxidative stress in chronic myocardial ischemia.
    J Thorac Cardiovasc Surg. 2018 Feb 2. pii: S0022-5223(18)30268.
    PubMed     Text format     Abstract available

  46. RANKIN JS, Roberts HG, Badhwar V
    Atrial fibrillation and coronary artery bypass grafting: The question is no longer why, but why not?
    J Thorac Cardiovasc Surg. 2018 Feb 17. pii: S0022-5223(18)30381.
    PubMed     Text format    

  47. NEES SN, Flyer JN, Chelliah A, Dayton JD, et al
    Patients with anomalous aortic origin of the coronary artery remain at risk after surgical repair.
    J Thorac Cardiovasc Surg. 2018 Feb 8. pii: S0022-5223(18)30307.
    PubMed     Text format     Abstract available

  48. MALAISRIE SC, McCarthy PM, Kruse J, Matsouaka R, et al
    Burden of preoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30312.
    PubMed     Text format     Abstract available


    JAMA

  49. NICHOLLS SJ, Psaltis PJ
    Lipid Lowering in Acute Coronary Syndrome: Is Treatment Early Enough?
    JAMA. 2018 Mar 11. pii: 2675022. doi: 10.1001/jama.2018.2426.
    PubMed     Text format    

  50. BERWANGER O, Santucci EV, de Barros E Silva PGM, Jesuino IA, et al
    Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
    JAMA. 2018 Mar 11. pii: 2675023. doi: 10.1001/jama.2018.2444.
    PubMed     Text format     Abstract available


    Lancet

  51. SHAH R
    Bioresorbable polymer drug-eluting stents.
    Lancet. 2018;391:935-936.
    PubMed     Text format    

  52. ALKHALIL M
    Bioresorbable polymer drug-eluting stents.
    Lancet. 2018;391:936.
    PubMed     Text format    

  53. KANDZARI DE, Mauri L, Koolen JJ, Doros G, et al
    Bioresorbable polymer drug-eluting stents - Authors' reply.
    Lancet. 2018;391:936-937.
    PubMed     Text format    


    N Engl J Med

  54. WHITE WB, Saag KG, Becker MA, Borer JS, et al
    Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
    N Engl J Med. 2018 Mar 12. doi: 10.1056/NEJMoa1710895.
    PubMed     Text format     Abstract available


    PLoS One

  55. LA TORRE G, Saulle R, Di Murro F, Siliquini R, et al
    Mediterranean diet adherence and synergy with acute myocardial infarction and its determinants: A multicenter case-control study in Italy.
    PLoS One. 2018;13:e0193360.
    PubMed     Text format     Abstract available

  56. SUN L, Zhou X, Jiang J, Zang X, et al
    Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis.
    PLoS One. 2018;13:e0194152.
    PubMed     Text format     Abstract available

  57. KHAN KB, Khaliq AA, Jalil A, Shahid M, et al
    A robust technique based on VLM and Frangi filter for retinal vessel extraction and denoising.
    PLoS One. 2018;13:e0192203.
    PubMed     Text format     Abstract available

  58. RAJA SG, Ilsley C, De Robertis F, Lane R, et al
    Mid-to-long term mortality following surgical versus percutaneous coronary revascularization stratified according to stent subtype: An analysis of 6,682 patients with multivessel disease.
    PLoS One. 2018;13:e0191554.
    PubMed     Text format     Abstract available


    Psychosom Med

  59. STEBENNE P, Bacon SL, Austin A, Paine NJ, et al
    Positive and Negative Affect Is Related to Experiencing Chest Pain During Exercise-Induced Myocardial Ischemia.
    Psychosom Med. 2017;79:395-403.
    PubMed     Text format     Abstract available


    Thromb Haemost

  60. KANG J, Han JK, Ahn Y, Chae SC, et al
    Third-Generation P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre Study.
    Thromb Haemost. 2018;118:591-600.
    PubMed     Text format     Abstract available

  61. ARIZA-SOLE A, Guerrero C, Formiga F, Aboal J, et al
    Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry.
    Thromb Haemost. 2018;118:581-590.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: